Primary |
Pain |
15.0% |
Neuralgia |
11.7% |
Neuropathy Peripheral |
11.0% |
Ill-defined Disorder |
6.5% |
Hypertension |
6.2% |
Fibromyalgia |
5.9% |
Depression |
5.6% |
Back Pain |
4.5% |
Diabetic Neuropathy |
4.2% |
Pain In Extremity |
3.8% |
Diabetes Mellitus |
3.6% |
Nerve Injury |
3.5% |
Bipolar Disorder |
3.3% |
Anxiety |
3.0% |
Convulsion |
2.7% |
Migraine |
2.0% |
Epilepsy |
2.0% |
Neuropathy |
2.0% |
Sleep Disorder |
1.8% |
Blood Cholesterol Increased |
1.8% |
|
Drug Ineffective |
14.9% |
Suicide Attempt |
14.7% |
Suicidal Ideation |
8.9% |
Weight Increased |
8.1% |
Drug Hypersensitivity |
7.4% |
Pain |
7.3% |
Somnolence |
6.6% |
Off Label Use |
3.7% |
Death |
3.7% |
Vision Blurred |
2.9% |
Pain In Extremity |
2.7% |
Weight Decreased |
2.6% |
Tremor |
2.6% |
Malaise |
2.3% |
Thinking Abnormal |
2.3% |
Vomiting |
2.3% |
Depression |
1.8% |
Feeling Abnormal |
1.8% |
Hypertension |
1.8% |
Completed Suicide |
1.7% |
|
Secondary |
Pain |
13.5% |
Neuropathy Peripheral |
8.9% |
Neuralgia |
8.2% |
Depression |
8.1% |
Product Used For Unknown Indication |
8.0% |
Fibromyalgia |
6.6% |
Hypertension |
6.0% |
Drug Use For Unknown Indication |
5.8% |
Anxiety |
4.5% |
Back Pain |
4.1% |
Pain In Extremity |
3.5% |
Nerve Injury |
3.4% |
Blood Cholesterol Increased |
2.8% |
Convulsion |
2.7% |
Ill-defined Disorder |
2.7% |
Diabetes Mellitus |
2.6% |
Diabetic Neuropathy |
2.5% |
Bipolar Disorder |
2.3% |
Sleep Disorder |
2.0% |
Arthritis |
1.7% |
|
Weight Increased |
14.2% |
Pain |
9.8% |
Drug Ineffective |
9.6% |
Suicide Attempt |
8.4% |
Somnolence |
7.0% |
Suicidal Ideation |
5.4% |
Off Label Use |
5.0% |
Weight Decreased |
4.2% |
Tremor |
4.0% |
Vision Blurred |
4.0% |
Pain In Extremity |
3.9% |
Withdrawal Syndrome |
3.9% |
Malaise |
2.9% |
Vomiting |
2.9% |
Death |
2.7% |
Paraesthesia |
2.6% |
Thinking Abnormal |
2.5% |
Nausea |
2.5% |
Renal Failure Acute |
2.3% |
Drug Hypersensitivity |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
26.1% |
Drug Use For Unknown Indication |
14.8% |
Pain |
10.1% |
Depression |
6.3% |
Multiple Sclerosis |
6.1% |
Hypertension |
4.9% |
Anxiety |
3.3% |
Diabetes Mellitus |
2.9% |
Multiple Myeloma |
2.8% |
Rheumatoid Arthritis |
2.7% |
Bipolar Disorder |
2.4% |
Gastrooesophageal Reflux Disease |
2.3% |
Back Pain |
2.2% |
Neuropathy Peripheral |
2.1% |
Sleep Disorder |
2.0% |
Neuralgia |
1.9% |
Nuclear Magnetic Resonance Imaging |
1.9% |
Osteoporosis |
1.8% |
Asthma |
1.8% |
Insomnia |
1.7% |
|
Vomiting |
12.6% |
Weight Decreased |
10.9% |
Weight Increased |
10.5% |
Type 2 Diabetes Mellitus |
7.8% |
Urinary Tract Infection |
5.0% |
Nausea |
4.7% |
Pain |
4.6% |
Vision Blurred |
4.4% |
Tremor |
4.1% |
Wrong Technique In Drug Usage Process |
4.1% |
Myocardial Infarction |
4.0% |
Pneumonia |
3.8% |
Drug Ineffective |
3.6% |
Somnolence |
3.2% |
Pain In Extremity |
2.9% |
Rash |
2.9% |
Pyrexia |
2.9% |
White Blood Cell Count Decreased |
2.7% |
Death |
2.7% |
Suicidal Ideation |
2.5% |
|
Interacting |
Product Used For Unknown Indication |
17.6% |
Dementia With Lewy Bodies |
16.0% |
Depression |
12.0% |
Pain |
11.7% |
Sleep Disorder |
4.3% |
Headache |
3.8% |
Drug Use For Unknown Indication |
3.7% |
Hypertension |
3.7% |
Ill-defined Disorder |
3.7% |
Neuropathy Peripheral |
3.2% |
Fibromyalgia |
2.9% |
Blood Viscosity Increased |
2.6% |
Diabetes Mellitus |
2.6% |
Epilepsy |
2.1% |
Rheumatoid Arthritis |
2.1% |
Anxiety |
1.9% |
Neuralgia |
1.8% |
Convulsion |
1.6% |
Migraine |
1.6% |
Anticoagulant Therapy |
1.4% |
|
Abnormal Behaviour |
18.5% |
Drug Interaction |
13.0% |
Syncope |
7.4% |
Sleep Disorder |
6.5% |
Hypothyroidism |
5.6% |
Weight Fluctuation |
5.6% |
Somnolence |
4.6% |
Dementia With Lewy Bodies |
3.7% |
Drug Ineffective |
3.7% |
Epilepsy |
3.7% |
Unevaluable Event |
3.7% |
Vomiting |
3.7% |
Mood Altered |
2.8% |
Oedema Peripheral |
2.8% |
Panic Disorder |
2.8% |
Vision Blurred |
2.8% |
Weight Increased |
2.8% |
Wrist Fracture |
2.8% |
Confusional State |
1.9% |
Facial Palsy |
1.9% |
|